STAT+: Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic

AI Summary

A U.N.-backed agency has signed sub-licensing deals for generic versions of Roche's influenza drug to enhance pandemic preparedness. This move aims to improve global access to effective flu treatments ahead of potential future pandemics.

With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals related to generic versions of a Roche influenza treatment.